These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 19175076

  • 1. [Current diagnosis of secondary hypertension associated with the endocrinopathies].
    Sakihara S.
    Rinsho Byori; 2008 Dec; 56(12):1112-7. PubMed ID: 19175076
    [Abstract] [Full Text] [Related]

  • 2. Endocrine arterial hypertension: diagnostic approach in clinical practice.
    Mazza A, Zamboni S, Armigliato M, Zennaro R, Cuppini S, Rempelou P, Rubello D, Pessina AC.
    Minerva Endocrinol; 2008 Jun; 33(2):127-46. PubMed ID: 18272953
    [Abstract] [Full Text] [Related]

  • 3. [Screening tests and diagnostic examinations of hypertensives for primary aldosteronism].
    Omura M, Nishikawa T.
    Rinsho Byori; 2006 Nov; 54(11):1157-63. PubMed ID: 17240838
    [Abstract] [Full Text] [Related]

  • 4. [Rational diagnosis of endocrine forms of hypertension].
    Mengden T, Vetter H, Marincek B, Edmonds D, Jeck T, Schubert M, Vetter W.
    Bildgebung; 2006 Nov; 56(4):132-40. PubMed ID: 3078251
    [Abstract] [Full Text] [Related]

  • 5. [Salivary cortisol in adrenal diseases].
    Løvås K, Husebye ES.
    Tidsskr Nor Laegeforen; 2007 Mar 15; 127(6):730-2. PubMed ID: 17363984
    [Abstract] [Full Text] [Related]

  • 6. [Diagnosis and therapy of endocrine hypertension].
    Unger N, Petersenn S, Mann K.
    Med Klin (Munich); 2006 Mar 22; 101 Suppl 1():170-2. PubMed ID: 16802547
    [Abstract] [Full Text] [Related]

  • 7. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
    Niizuma S, Nakahama H, Kamide K, Fukuchi K, Iwanaga Y, Nakata H, Yoshihara F, Horio T, Nakamura S, Kawano Y.
    Clin Exp Hypertens; 2008 Oct 22; 30(7):640-7. PubMed ID: 18855267
    [Abstract] [Full Text] [Related]

  • 8. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
    Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello MJ, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC, Mantero F, PAPY Study Investigators.
    J Am Coll Cardiol; 2006 Dec 05; 48(11):2293-300. PubMed ID: 17161262
    [Abstract] [Full Text] [Related]

  • 9. Primary aldosteronism: renaissance of a syndrome.
    Young WF.
    Clin Endocrinol (Oxf); 2007 May 05; 66(5):607-18. PubMed ID: 17492946
    [Abstract] [Full Text] [Related]

  • 10. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol.
    Giacchetti G, Ronconi V, Lucarelli G, Boscaro M, Mantero F.
    J Hypertens; 2006 Apr 05; 24(4):737-45. PubMed ID: 16531803
    [Abstract] [Full Text] [Related]

  • 11. [How to screen for pheochromocytoma, primary aldosteronism and Cushing's syndrome].
    Meyer P.
    Rev Med Suisse; 2009 Jan 07; 5(185):15-8. PubMed ID: 19216319
    [Abstract] [Full Text] [Related]

  • 12. Recent advances in diagnosis and treatment of primary aldosteronism.
    Veglio F, Morello F, Rabbia F, Leotta G, Mulatero P.
    Minerva Med; 2003 Aug 07; 94(4):259-65. PubMed ID: 14605590
    [Abstract] [Full Text] [Related]

  • 13. Detecting and treating primary aldosteronism: primary aldosteronism.
    Mantero F, Mattarello MJ, Albiger NM.
    Exp Clin Endocrinol Diabetes; 2007 Mar 07; 115(3):171-4. PubMed ID: 17427105
    [Abstract] [Full Text] [Related]

  • 14. Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma.
    Rossi GP, Belfiore A, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Montemurro D, Palumbo G, Rizzoni D, Rossi E, Semplicini A, Agabiti-Rosei E, Pessina AC, Mantero F, PAPY Study Investigators.
    J Hypertens; 2007 Jul 07; 25(7):1433-42. PubMed ID: 17563566
    [Abstract] [Full Text] [Related]

  • 15. Bilateral co-secretory lesions presenting with coexisting Cushing syndrome and primary aldosteronism: a case report.
    Gao H, Li L, Chen F, Ren Y, Chen T, Tian H.
    BMC Endocr Disord; 2023 Nov 29; 23(1):263. PubMed ID: 38017509
    [Abstract] [Full Text] [Related]

  • 16. Late-night salivary cortisol measurement in the diagnosis of Cushing's syndrome.
    Carroll T, Raff H, Findling JW.
    Nat Clin Pract Endocrinol Metab; 2008 Jun 29; 4(6):344-50. PubMed ID: 18446140
    [Abstract] [Full Text] [Related]

  • 17. [Therapy-resistant hypertension--the endocrinological view].
    Beuschlein F, Reincke M.
    MMW Fortschr Med; 2007 Mar 01; 149(9):29-32. PubMed ID: 17612246
    [Abstract] [Full Text] [Related]

  • 18. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan.
    Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T.
    Hypertens Res; 2004 Mar 01; 27(3):193-202. PubMed ID: 15080378
    [Abstract] [Full Text] [Related]

  • 19. [Endocrine hypertension].
    Poulsen PL, Ibsen H.
    Ugeskr Laeger; 2009 Jun 15; 171(25):2100-3. PubMed ID: 19671390
    [Abstract] [Full Text] [Related]

  • 20. Salivary cortisol measurement--a reliable method for the diagnosis of Cushing's syndrome.
    Trilck M, Flitsch J, Lüdecke DK, Jung R, Petersenn S.
    Exp Clin Endocrinol Diabetes; 2005 Apr 15; 113(4):225-30. PubMed ID: 15891959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.